172 related articles for article (PubMed ID: 2478059)
1. Dexamethasone does not inhibit the release of mediators from human mast cells residing in airway, intestine, or skin.
Cohan VL; Undem BJ; Fox CC; Adkinson NF; Lichtenstein LM; Schleimer RP
Am Rev Respir Dis; 1989 Oct; 140(4):951-4. PubMed ID: 2478059
[TBL] [Abstract][Full Text] [Related]
2. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.
Columbo M; Horowitz EM; Botana LM; MacGlashan DW; Bochner BS; Gillis S; Zsebo KM; Galli SJ; Lichtenstein LM
J Immunol; 1992 Jul; 149(2):599-608. PubMed ID: 1378071
[TBL] [Abstract][Full Text] [Related]
3. Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells.
Schleimer RP; Schulman ES; MacGlashan DW; Peters SP; Hayes EC; Adams GK; Lichtenstein LM; Adkinson NF
J Clin Invest; 1983 Jun; 71(6):1830-5. PubMed ID: 6134755
[TBL] [Abstract][Full Text] [Related]
4. Isoproterenol-induced inhibition of immunoglobulin E-mediated release of histamine and arachidonic acid metabolites from the human lung mast cell.
Undem BJ; Peachell PT; Lichtenstein LM
J Pharmacol Exp Ther; 1988 Oct; 247(1):209-17. PubMed ID: 2459368
[TBL] [Abstract][Full Text] [Related]
5. Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells.
Casolaro V; Meliota S; Marino O; Patella V; de Paulis A; Guidi G; Marone G
J Pharmacol Exp Ther; 1993 Dec; 267(3):1375-85. PubMed ID: 7505332
[TBL] [Abstract][Full Text] [Related]
6. Regulation of mediator release from mouse bone marrow-derived mast cells by glucocorticoids.
Robin JL; Seldin DC; Austen KF; Lewis RA
J Immunol; 1985 Oct; 135(4):2719-26. PubMed ID: 3161947
[TBL] [Abstract][Full Text] [Related]
7. Characterization of primate bronchoalveolar mast cells. II. Inhibition of histamine, LTC4, and PGD2 release from primate bronchoalveolar mast cells and a comparison with rat peritoneal mast cells.
Wells E; Jackson CG; Harper ST; Mann J; Eady RP
J Immunol; 1986 Dec; 137(12):3941-5. PubMed ID: 2431049
[TBL] [Abstract][Full Text] [Related]
8. Generation of leukotriene C4, leukotriene B4, and prostaglandin D2 by immunologically activated rat intestinal mucosa mast cells.
Heavey DJ; Ernst PB; Stevens RL; Befus AD; Bienenstock J; Austen KF
J Immunol; 1988 Mar; 140(6):1953-7. PubMed ID: 2450136
[TBL] [Abstract][Full Text] [Related]
9. Co-culture of human lung-derived mast cells with mouse 3T3 fibroblasts: morphology and IgE-mediated release of histamine, prostaglandin D2, and leukotrienes.
Levi-Schaffer F; Austen KF; Caulfield JP; Hein A; Gravallese PM; Stevens RL
J Immunol; 1987 Jul; 139(2):494-500. PubMed ID: 2439587
[TBL] [Abstract][Full Text] [Related]
10. Anaphylactic- and calcium-dependent generation of prostaglandin D2 (PGD2), thromboxane B2, and other cyclooxygenase products of arachidonic acid by dispersed human lung cells and relationship to histamine release.
Holgate ST; Burns GB; Robinson C; Church MK
J Immunol; 1984 Oct; 133(4):2138-44. PubMed ID: 6206153
[TBL] [Abstract][Full Text] [Related]
11. The ascomycin macrolactam pimecrolimus (Elidel, SDZ ASM 981) is a potent inhibitor of mediator release from human dermal mast cells and peripheral blood basophils.
Zuberbier T; Chong SU; Grunow K; Guhl S; Welker P; Grassberger M; Henz BM
J Allergy Clin Immunol; 2001 Aug; 108(2):275-80. PubMed ID: 11496246
[TBL] [Abstract][Full Text] [Related]
12. Characterization of primate bronchoalveolar mast cells. I. IgE-dependent release of histamine, leukotrienes, and prostaglandins.
Wells E; Harper ST; Jackson CG; Mann J; Eady RP
J Immunol; 1986 Dec; 137(12):3933-40. PubMed ID: 2431048
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the anti-inflammatory effect of FK-506 on human mast cells.
de Paulis A; Cirillo R; Ciccarelli A; de Crescenzo G; Oriente A; Marone G
J Immunol; 1991 Dec; 147(12):4278-85. PubMed ID: 1721644
[TBL] [Abstract][Full Text] [Related]
14. Human basophil/mast cell releasability. VII. Heterogeneity of the effect of adenosine on mediator secretion.
Marone G; Cirillo R; Genovese A; Marino O; Quattrin S
Life Sci; 1989; 45(19):1745-54. PubMed ID: 2480501
[TBL] [Abstract][Full Text] [Related]
15. Human basophil/mast cell releasability. IX. Heterogeneity of the effects of opioids on mediator release.
Stellato C; Cirillo R; de Paulis A; Casolaro V; Patella V; Mastronardi P; Mazzarella B; Marone G
Anesthesiology; 1992 Nov; 77(5):932-40. PubMed ID: 1280014
[TBL] [Abstract][Full Text] [Related]
16. General anaesthetics induce only histamine release selectively from human mast cells.
Stellato C; Casolaro V; Ciccarelli A; Mastronardi P; Mazzarella B; Marone G
Br J Anaesth; 1991 Dec; 67(6):751-8. PubMed ID: 1722691
[TBL] [Abstract][Full Text] [Related]
17. IgE-mediated release of leukotriene C4, chondroitin sulfate E proteoglycan, beta-hexosaminidase, and histamine from cultured bone marrow-derived mouse mast cells.
Razin E; Mencia-Huerta JM; Stevens RL; Lewis RA; Liu FT; Corey E; Austen KF
J Exp Med; 1983 Jan; 157(1):189-201. PubMed ID: 6184439
[TBL] [Abstract][Full Text] [Related]
18. Mouse bone marrow-derived mast cells cocultured with fibroblasts. Morphology and stimulation-induced release of histamine, leukotriene B4, leukotriene C4, and prostaglandin D2.
Levi-Schaffer F; Dayton ET; Austen KF; Hein A; Caulfield JP; Gravallese PM; Liu FT; Stevens RL
J Immunol; 1987 Nov; 139(10):3431-41. PubMed ID: 2445814
[TBL] [Abstract][Full Text] [Related]
19. Oxatomide inhibits the release of proinflammatory mediators from human basophils and mast cells.
Patella V; de Crescenzo G; Marino O; Spadaro G; Genovese A; Marone G
Int Arch Allergy Immunol; 1996 Sep; 111(1):23-9. PubMed ID: 8753840
[TBL] [Abstract][Full Text] [Related]
20. Disassociation of the release of histamine and arachidonic acid metabolites from osmotically activated basophils and human lung mast cells.
Eggleston PA; Kagey-Sobotka A; Proud D; Adkinson NF; Lichtenstein LM
Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):960-4. PubMed ID: 1691604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
